News Home

What is the Market's View on Vaxart Inc (VXRT) Stock's Price and Volume Trends

Tuesday, November 24, 2020 03:37 PM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Vaxart Inc (VXRT) Stock's Price and Volume Trends

Vaxart Inc (VXRT) stock is up 11.29% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.

Sentiment Score - ,bullish
Vaxart Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on VXRT!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With VXRT Stock Today?

Vaxart Inc (VXRT) stock is lower by -11.31% while the S&P 500 has gained 0.57% as of 3:35 PM on Tuesday, Nov 24. VXRT is down -$0.80 from the previous closing price of $7.12 on volume of 9,668,379 shares. Over the past year the S&P 500 is up 14.17% while VXRT has gained 1935.48%. VXRT lost -$0.35 per share in the over the last 12 months.

To see InvestorsObserver's Sentiment Score for Vaxart Inc click here.

More About Vaxart Inc

Vaxart Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; Influenza, Norovirus and RSV Vaccine, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus.

Click Here to get the full Stock Score Report on Vaxart Inc (VXRT) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App